Study of SC10914 in Patients With gBRCA1/2 Mutation Advanced Ovarian Cancer

Inclusion Criteria

• •1. Sign informed consent voluntarily;
• •2. ≥18 years old;
• •3. Histologically confirmed ovarian epithelial cancer, fallopian tube cancer or primary peritoneal cancer( high-grade carcinoma cancer or endometrioid carcinoma);
• •4. gBRCA1/2 mutation positive;
• •5. Had recived at least 2 prior lines of chemotherapy;
• •6. Platinum sensitive patients;
• •7. The last line of therapy befor enrollment failed；
• •8. ECOG≤2；
• •8\. Had at least one measurable lesion.